
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.66394
Neurology
Otolaryngology
Oncology
An Unusual and Discrepant Presentation of a Skull Base Paraganglioma
Muacevic Alexander
Adler John R
Patel Raj 1
Allam Yusuf A 2
Shukairy Mohammad K 1
Kircher Matthew 1
1 Otolaryngology, Loyola University Medical Center, Maywood, USA
2 Anatomical Sciences, University of Michigan, Ann Arbor, USA
Raj Patel rpatel61@luc.edu
7 8 2024
8 2024
16 8 e663947 8 2024
Copyright © 2024, Patel et al.
2024
Patel et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/260554-an-unusual-and-discrepant-presentation-of-a-skull-base-paraganglioma
Paragangliomas are rare tumors of neuroendocrine origin. Within the head and neck, these tumors are slow-growing and locally destructive, with a small malignant potential. Vagal paragangliomas (VPs) originate from paraganglia around the vagus nerve, typically at the level of the skull base. Cranial nerve deficits are common at presentation, with the vagus nerve and hypoglossal nerves being most affected. Similarly, hypoglossal paragangliomas (HPs) originate from around the hypoglossal nerve but are extremely rare and less documented. We describe the case of a patient presenting with an isolated hypoglossal nerve palsy in the setting of a tumor that radiologically represents a VP. A descriptive literature review was conducted to highlight presentation, management, and outcomes related to this pathology.

A 65-year-old male presented to the clinic with tongue fasciculations and several years of dysarthria. Physical examination showed intermittent right tongue fasciculations in addition to ipsilateral hemi-atrophy. A computed tomography scan with contrast revealed an enhancing skull base mass inferior to the right carotid space. Subsequently, magnetic resonance imaging with contrast further delineated its anatomic involvement and site of origin, allowing for the diagnosis of a VP. After further discussion with the patient about his clinical findings, the decision was made to proceed with observation and serial imaging.

Skull base paragangliomas are a rare pathologic entity that may pose a challenging multidisciplinary approach to optimize management strategies. Treatment may vary on a case-by-case basis and is dependent on patient and tumor characteristics.

clinical neurotology
neuroendocrine tumors (nets)
head and neck cancer surgery
neurogenic tumor of head and neck
isolated hypoglossal nerve palsy
vagal paraganglioma
==== Body
pmcIntroduction

Paragangliomas are rare neuroendocrine tumors in the head and neck, characterized by slow growth, local destruction, and low malignant potential [1]. These tumors account for 0.6% of all head and neck tumors [2,3]. While typically benign, head and neck paragangliomas, in particular vagal paragangliomas (VPs), exhibit rare malignant potential, and their etiology remains poorly understood.

VPs are derived from the perineurium in the paraganglionic tissue of the vagus nerve and comprise 5% of head and neck paragangliomas [1,4]. Although these tumors may arise from anywhere along the course of the vagus nerve, they typically originate from the inferior nodose ganglion [5]. The clinical presentation of VPs depend on tumor size and location and most commonly present as a painless neck mass. However, cranial nerve deficits are common at presentation with the vagus nerve being most commonly involved [4,5].

In contrast to VPs, hypoglossal paragangliomas (HPs) are exceptionally rare, with fewer than 10 cases reported in the literature [6-11]. However, the proximity of the hypoglossal nerve to the carotid sheath may make a definitive diagnosis based on imaging alone very difficult, as tumors originating from the nerve may mimic VPs or carotid body tumors [11]. Although unilateral tongue weakness and wasting may raise suspicion for hypoglossal nerve origin, its involvement in other skull base paragangliomas makes this diagnosis particularly challenging. Furthermore, a painless neck mass with an indolent growth pattern as a presenting symptom is commonly described in these tumors, imitating VPs [11].

In this report, we describe the case of a patient who presents with an isolated hypoglossal nerve deficit in the setting of a skull base mass radiographically consistent with a VP. The discrepant clinical and radiographic nature of this tumor, to our knowledge, is the first described case of its kind. A comprehensive examination of the current understanding of VPs and HPs is also included.

Case presentation

A 65-year-old male with a past medical history significant for hypothyroidism, hypertension, dyslipidemia, gastroesophageal reflux disease, and cataracts presented to the otolaryngology clinic for tongue discomfort. Upon further questioning, the patient reported a several-year history of dysarthria, specifically when pronouncing the letter “L.” He also noted occasional tongue biting on the right side. These findings have been stable since onset, and he denied pain, dysphonia, or dysphagia.

Physical examination showed hemi-atrophy of the right tongue as well as ipsilateral fasciculations. CT scan of the neck displayed a heterogeneously enhancing mass centered in the right carotid space (Figure 1). Follow-up MRI of the neck demonstrated an enhancing 4.5 × 2.0 × 5.5 cm mass in the jugular foramen with medial involvement into the hypoglossal canal and inferior extension into the right carotid space. There was noted anterior displacement of the right carotid artery with characteristic intratumoral flow voids (Figure 2) and fatty infiltration of the right tongue with ipsilateral tongue atrophy (Figure 2C).

Due to the unusual incongruity between the clinical and radiographic findings, imaging was reviewed with a neuroradiologist at our institution, and it was determined that the epicenter of the mass was likely stemming off the vagus nerve. Treatment options entailing surgery and education regarding the patient’s clinical situation were discussed in detail. The patient decided not to undergo surgery at the moment to prioritize treatment for other health conditions. The patient is currently being managed with observation and serial imaging, where they will follow up in six months.

Figure 1 Computed tomography showing an enhancing mass (red arrows) along the right skull base with extension into the jugular foramen and hypoglossal canal. The internal carotid artery is displaced anteromedially. A) Coronal. B) Sagittal. C) Axial.

Figure 2 Magnetic resonance imaging depicting a heterogeneously enhancing mass (red arrows) with anterior displacement of the internal carotid artery. The right internal jugular vein flow void is inseparable from the mass. There is notable fatty atrophy and edema involving the intrinsic musculature of the right tongue (green arrow). A) Coronal, T1 sequence post-contrast. B) Coronal, T2 sequence. C) Axial, T1 sequence post-contrast.

Discussion

Skull base paragangliomas are rare benign tumors that often present in the head and neck region, typically originating near critical structures such as the carotid artery, jugular vein, or cranial nerves. In this report, we present a unique case demonstrating radiologic findings consistent with a VP yet exhibiting clinical signs indicative of an HP. The discrepant nature of these findings underscores the complexity of diagnosing skull base paragangliomas. The following discussion will focus on vagal and HPs, emphasizing the importance of a multidisciplinary approach in accurately identifying and managing these tumors.

Overview and presentation

VPs are rare but well-established entities in the medical literature, with an incidence of approximately one in 100,000 and a slight female predilection. These tumors typically present around the age of 45 years. Up to 50% of cases have a genetic basis, often manifesting with a younger age of onset and multifocality [5,12]. Specifically, genes encoding different subunits of the succinate dehydrogenase (SDH) enzyme complex have been implicated [2]. Among head and neck paragangliomas, VPs are notable for their highest malignant potential [1]. It is worth noting that there is no standardized staging system; instead, malignancy is determined by the presence of regional or distant metastasis, which has been associated with higher mortality rates [1,3,13].

The natural history of VPs remains incompletely understood and depends on tumor size, location, and clinical factors such as involved neurovascular structures. A growing proportion of tumors may be found incidentally, considering the more frequent usage of cross-sectional imaging [2,14]. However, VPs most commonly present as a painless lateral neck mass. Cranial nerve deficits are also common at presentation, with the vagus nerve and hypoglossal nerves experiencing deficits of around 28-37% and 17-21%, respectively [4,5]. Other less commonly involved cranial nerves include the spinal accessory, glossopharyngeal, and facial nerves [4]. Additionally, some patients may experience Horner syndrome based on tumor proximity to the sympathetic nerve pathway [5]. In contrast to paragangliomas present at other sites of the body, head and neck tumors rarely secrete catecholamines, with an estimated incidence of 2-5% [5,15]. Similar to pheochromocytomas, secretory tumors that produce vasoactive substances can cause symptoms of catecholamine excess, typically presenting as hypertension and/or tachycardia. The wide array of clinical symptoms is attributed to the various potential sites of origin along the course of the vagus nerve and the corresponding local involvement.

VPs usually originate from the first 2 cm of the extracranial course of the vagus nerve and most commonly are associated with the inferior vagal or nodose ganglion [16]. They may be limited to the cervical region, be firmly attached to the skull base, or extend intracranially. Some authors believe that the ganglion of origin of the VPs may determine the clinical presentation and growth pattern of the lesion. For instance, lesions arising from the inferior (nodose) ganglion tend to remain limited to the cervical region, whereas tumors from the middle ganglion are cone-shaped and attached to the skull base. Tumors from the superior (jugular) ganglion are usually dumbbell-shaped with intracranial and cervical components.

HPs are exceptionally rare, with fewer than 10 cases reported in the literature [6,9-11]. The radiographic findings seen in our patient were more suggestive of a vagal origin. However, the close proximity of these tumors to the carotid vessels has rendered pre-operative diagnosis exceedingly challenging. Moreover, associated neurological symptoms from brainstem compression have been described and may complicate the clinical picture [7].

To our knowledge, our report described the only case of isolated hypoglossal nerve palsy attributed to a preliminary diagnosis of VP. The presentation of an isolated hypoglossal nerve palsy was acknowledged as being unusual, which prompted a further review of the imaging with the neuroradiologist at our institution. Despite further review, the MRI findings were most suggestive of a VP. The right internal carotid artery was noted to be anteriorly displaced, and the right internal jugular vein flow void was inseparable from the mass. Although there was an extension into the hypoglossal canal, the epicenter appeared to be along the vagus nerve.

Diagnosis and treatment

Initial evaluation begins with a thorough history and physical examination, with special attention paid to cranial nerve function. When suspicion for a head and neck paraganglioma is raised based on clinical signs or symptoms, family history, or incidental findings on imaging, appropriate diagnosis and management become essential.

Imaging characteristics coupled with the appropriate clinical scenario are sufficiently distinctive to permit an accurate diagnosis. A CT scan of the head and neck is an appropriate initial choice as it defines the boundaries of the mass and highlights any local bony destruction within the surrounding architecture [2,13]. A homogenous mass with intense enhancement upon the administration of intravenous contrast is classically seen. MRI is complementary to CT as it allows for enhanced soft tissue detail, which is imperative in the setting of skull base pathology, where critical neurovascular structures exist.

VPs characteristically displace both the internal and external carotids anteriorly, which is in contrast to carotid body tumors where the internal carotid artery is displaced in a posterolateral direction [17]. Evaluation by T1-weighted MRI often reveals paragangliomas with a signal intensity intermediate to surrounding tissues. These lesions frequently demonstrate foci of signal void, attributed to the presence of high-flow vasculature within the tumor. T2-weighted MRI sequences classically show a “salt and pepper" appearance, which manifests as a heterogeneous distribution of signal voids interspersed with regions of focally high signal intensity. It is worth noting that these findings can be observed in other hypervascular tumors and are not specific to paragangliomas [18]. Additionally, in the setting of a newly diagnosed head and neck paraganglioma, some groups advocate for imaging of the thorax, abdomen, and pelvis to exclude metastatic or synchronous paragangliomas using an MRI skull base to pelvis or alternatively a Gallium Ga-68 DOTATATE positron emission tomography (PET) CT [2,19].

Despite the rare incidence of functional paragangliomas within the head and neck, all patients should undergo biochemical testing to avoid precipitating a catecholamine crisis. A catecholamine crisis is a life-threatening emergency where the adrenal gland produces high levels of catecholamines, such as noradrenaline and adrenaline. These high levels can cause induced hypertension that can lead to organ failure and cardiovascular complications. Testing is performed by measurements of urinary and/or plasma fractionated metanephrines and catecholamines. If significant elevations are detected, additional workup may be warranted to evaluate for synchronous paragangliomas located elsewhere in the body.

The only current curative option for head and neck paragangliomas is surgical excision. Observation is also an appropriate treatment route in the suitable patient population. The decision must be made after the consideration of several factors, including the size and location of the tumor, the status of cranial nerve function pre-operatively, and the patient's age and comorbid conditions [12]. Due to the intricate neurovascular structures involved or closely situated to these tumors, their management can present significant challenges. Preserving cranial nerve function through nerve monitoring is paramount in any curative treatment approach. In the case of VPs, surgical intervention inevitably leads to vagus nerve injury, even in the absence of intimate involvement [12]. Intraoperatively diagnosed VPs without pre-operative vagal weakness, especially when initially suspected to be carotid body tumors, may warrant a shift toward nonsurgical management to avoid unnecessary risks of damaging the vagus nerve. The role of radiation therapy for the treatment of VPs has been associated with several serious complications, including skull base osteomyelitis, and currently lacks a strong evidence base [12,20]. By the same principle, the treatment modalities for suspected HPs must be carefully considered in the context of the patient’s clinical condition to avoid unnecessary morbidity. Given the rarity of these tumors and the diagnostic challenges, treatment guidelines have not been established.

Conclusions

Paragangliomas are rare neuroendocrine tumors that originate from neural crest cells and can occur in various locations within the head and neck. Among these, VPs typically arise from the vagus nerve, presenting frequently as painless neck masses with common cranial nerve deficits, particularly affecting the vagus nerve followed by the hypoglossal nerve. In contrast, HPs are very uncommon and pose significant difficulties because of their close location to the carotid sheath and their resemblance to other skull base tumors. Treatment strategies aim to balance tumor control with the preservation of neurological function. This case report highlights a 65-year-old male with an isolated hypoglossal nerve palsy and a skull base mass radiographically consistent with a VP, marking a unique presentation that underscores the complexities in diagnosing and managing these tumors. A multidisciplinary approach is essential for optimizing treatment, and it must be tailored to individual patients and tumor characteristics, given the absence of established guidelines.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Raj Patel, Mohammad K. Shukairy, Yusuf A. Allam, Matthew Kircher

Acquisition, analysis, or interpretation of data:  Raj Patel, Mohammad K. Shukairy, Yusuf A. Allam, Matthew Kircher

Drafting of the manuscript:  Raj Patel, Mohammad K. Shukairy, Yusuf A. Allam, Matthew Kircher

Critical review of the manuscript for important intellectual content:  Raj Patel, Mohammad K. Shukairy, Yusuf A. Allam, Matthew Kircher

Supervision:  Mohammad K. Shukairy, Matthew Kircher
==== Refs
References

1 Malignant vagal paraganglioma Head Neck Pathol Hamersley ER Barrows A Perez A Schroeder A Castle JT 201 205 10 2016 25712400
2 Contemporary management of paragangliomas of the head and neck Laryngoscope Investig Otolaryngol Cleere EF Martin-Grace J Gendre A Sherlock M O'Neill JP 93 107 7 2022
3 National Cancer Data Base report on malignant paragangliomas of the head and neck Cancer Lee JH Barich F Karnell LH Robinson RA Zhen WK Gantz BJ Hoffman HT 730 737 94 2002 11857306
4 Vagal paraganglioma: a review of 46 patients treated during a 20-year period Arch Otolaryngol Head Neck Surg Netterville JL Jackson CG Miller FR Wanamaker JR Glasscock ME 1133 1140 124 1998 9776192
5 Vagal paraganglioma: the Jefferson experience Otolaryngol Head Neck Surg Miller RB Boon MS Atkins JP Lowry LD 482 487 122 2000 10740165
6 Solitary paraganglioma of the hypoglossal nerve: a case report with magnetic resonance imaging findings Am J Case Rep Beyazal M Yavuz A Unal O Cankaya H Yılmaz D 419 423 14 2013 24349604
7 A case of paraganglioma of the hypoglossal nerve J Laryngol Otol Farr MR Martin TP Walsh AR Irving RM 0 124 2010
8 Paraganglioma of the hypoglossal nerve Laryngoscope Fink DS Benoit MM Lamuraglia GM Deschler DG 0 120 Suppl 4 2010
9 Solitary paraganglioma of the hypoglossal nerve: case report Neurosurgery Raza K Kaliaperumal C Farrell M O'Dwyer JA Pidgeon C 0 4 68 2011
10 Paraganglioma of the hypoglossal nerve J Vasc Surg Santovito D Conforti M Varetto G Rispoli P 1053 1055 49 2009 19341894
11 Hypoglossal nerve paraganglioma depicting as glomus tumor of neck Iran J Otorhinolaryngol Shamsi ZA Shaikh FA Wasif M Chaudhry MB Siddiqui NA Sophie Z 113 117 33 2021 33912488
12 Vagal paraganglioma Skull Base Zanoletti E Mazzoni A 161 167 16 2006 17268589
13 Head and neck paragangliomas Head Neck Mendenhall WM Amdur RJ Vaysberg M Mendenhall CM Werning JW 1530 1534 33 2011 21928426
14 Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients J Clin Endocrinol Metab Erickson D Kudva YC Ebersold MJ Thompson GB Grant CS van Heerden JA Young WF Jr 5210 5216 86 2001 11701678
15 Diagnosis and management of catecholamine secreting glomus tumors Laryngoscope Schwaber MK Glasscock ME Nissen AJ Jackson CG Smith PG 1008 1015 94 1984 6087052
16 Vagal paragangliomas Otolaryngol Clin North Am Sniezek JC Netterville JL Sabri AN 925 939 34 2001 11557447
17 Paragangliomas of the head and neck: radiologic-pathologic correlation Radiographics Rao AB Koeller KK Adair CF 1605 1632 19 1999 10555678
18 Multidisciplinary management of paragangliomas of the head and neck, part 1 Oncology (Williston Park) Hu K Persky MS 983 993 17 2003 https://pubmed.ncbi.nlm.nih.gov/12886866/ 12886866
19 British skull base society clinical consensus document on management of head and neck paragangliomas Otolaryngol Head Neck Surg Lloyd S Obholzer R Tysome J 400 409 163 2020 32340547
20 Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy Head Neck Suárez C Rodrigo JP Bödeker CC 1195 1204 35 2013 22422597
